Meningioma: all 233 studies
Page 2 of 3. Open to participants first (90), then studies with results posted, then the rest; newest registration first within each.
- An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent MeningiomaActive, not recruitingNCT02648997Phase 2Results posted
- Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and MeningiomaTerminatedNCT02282917Early Phase 1Results posted
- Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsTerminatedNCT02255461Phase 1Results posted
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicableResults posted
- Phase IV Bioseal Study in Brain Tumor SurgeryCompletedNCT02034799Phase 4Results posted
- T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerCompletedNCT01967823Phase 2Results posted
- Stereotactic Body Radiotherapy for Spine TumorsCompletedNCT01347307Not applicableResults posted
- Bevacizumab in Treating Patients With Recurrent or Progressive MeningiomasCompletedNCT01125046Phase 2Results posted
- Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial MeningiomaTerminatedNCT00972335Phase 2Results posted
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III MeningiomaCompletedNCT00895622Phase 2Results posted
- Monthly SOM230C for Recurrent or Progressive MeningiomaCompletedNCT00859040Phase 2Results posted
- Phase II Study of SOM230 in Patients With Recurrent or Progressive MeningiomaTerminatedNCT00813592Phase 2Results posted
- Combination of Hydroxyurea and Verapamil for Refractory MeningiomasCompletedNCT00706810Phase 2Results posted
- Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2Results posted
- Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
- Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive MeningiomaCompletedNCT00354913Phase 2Results posted
- Vatalanib in Treating Patients With Recurrent or Progressive MeningiomaCompletedNCT00348790Phase 2Results posted
- Imatinib Mesylate in Treating Patients With Recurrent MeningiomaCompletedNCT00045734Phase 2Results posted
- Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaCompletedNCT00045110Phase 1/2Results posted
- S9811 Hydroxyurea in Treating Patients With Unresectable Benign MeningiomaCompletedNCT00003590Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With MeningiomaTerminatedNCT00003483Phase 2Results posted
- China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial AneurysmActive, not recruitingNCT07809178
- Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid TherapyCompletedNCT07476404
- 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk MeningiomaSuspendedNCT07353229Phase 1
- Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MINDActive, not recruitingNCT07282470
- Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot StudyCompletedNCT06721130
- A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent MeningiomaCompletedNCT06668987Phase 1/2
- Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for MeningiomaCompletedNCT06614205
- Measuring and Mapping Cognitive Decline After Brain RadiosurgeryActive, not recruitingNCT06466720
- Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor DosimetryCompletedNCT06460467
- CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot TrialCompletedNCT06439420Phase 2
- Impact of External Drainage of the Lumbar Cistern in Patients With Hydrocephalus Following Meningioma Surgery and Its Influence on Patient SatisfactionCompletedNCT06383169
- Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentCompletedNCT06322342Phase 2
- Clinical Outcomes and Decision-making Choice of Skull Base Approaches for Petroclival MeningiomasCompletedNCT06319664
- Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotideCompletedNCT06255249
- Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH AdenomasCompletedNCT06180226
- A Study of ONC201 for Refractory MeningiomaWithdrawnNCT06012929Phase 2
- Role of the Tumor Microenvironment in Aggressive MeningiomasStatus unknownNCT05821790
- Petro-trigeminal Line and Petrous Apex CephalocelesCompletedNCT05639491
- Semi-automated Segmentation Methods of SSTR PET for Dosimetry PredictionCompletedNCT05537675
- Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood FlowCompletedNCT05305378
- Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical MeningiomasStatus unknownNCT05259332
- Automated Segmentation and Volumetry for Meningioma Using Deep LearningCompletedNCT05093751
- Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During NeurosurgeryCompletedNCT05028400Not applicable
- Study of the Inflammatory Microenvironment in Atypical MeningiomasStatus unknownNCT04761653
- Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle FunctionCompletedNCT04756050Phase 4
- Use of Non-invasive Optical Analysis in NeurosurgeryStatus unknownNCT04712214Not applicable
- Sphenoorbital Meningioma Management.Status unknownNCT04710485
- Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent MeningiomaActive, not recruitingNCT04659811Phase 2
- PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRIActive, not recruitingNCT04638478
- The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas ResectionCompletedNCT04595786Not applicable
- Establishment and Characterization of Meningioma Patient-derived OrganoidsCompletedNCT04478877
- Tranexamic Acid Reduce Blood Loss in Meningioma ResectionStatus unknownNCT04386642Phase 4
- Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.CompletedNCT04367779
- Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOCWithdrawnNCT04298541Phase 2
- 9-ING-41 in Pediatric Patients With Refractory Malignancies.TerminatedNCT04239092Phase 1
- MiDura-Study (Neuro-Patch in Duraplasty)Active, not recruitingNCT04189172
- MEningioma Detection Using Non Contrast MRI TecHniquEsTerminatedNCT04113408
- Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of GadoliniumCompletedNCT04113395
- Meningiomas and Treatment With CYPROTERONE ACETATE or ProgestinCompletedNCT04109404
- Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT04087902
- Closed vs. Open Face Masks for Cranial RadiotherapyCompletedNCT04079595Not applicable
- Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk MeningiomaActive, not recruitingNCT03971461Phase 2
- Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With MeningiomasCompletedNCT03953131Phase 1
- Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™CompletedNCT03936426Phase 1/2
- Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery QualityCompletedNCT03648034Not applicable
- Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaActive, not recruitingNCT03604978Phase 1/2
- DOTATOC PET/CT for Imaging NET PatientsActive, not recruitingNCT03583528
- Predictive Factors of Visual Recovery After Paraoptic Tumors RemovalCompletedNCT03567486
- Protocol for Evaluating a Planning Algorithm for Gamma Knife RadiosurgeryStatus unknownNCT03520829
- Comparative Study Between Different Approaches to CPA-petroclival MeningiomasStatus unknownNCT03462914
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory MeningiomaTerminatedNCT03267836Phase 1
- Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain TumorsActive, not recruitingNCT03220646Phase 2
- Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.Status unknownNCT03190122Phase 4
- Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryActive, not recruitingNCT03180268Phase 3
- Vistusertib (AZD2014) For Recurrent Grade II-III MeningiomasStatus unknownNCT03071874Phase 2
- S9005 Mifepristone in MeningiomaCompletedNCT03015701Phase 3
- Dosimetry Guided PRRT With 90Y-DOTATOCWithdrawnNCT03013387Phase 2
- 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedNCT03001349Early Phase 1
- Multisession Radiosurgery in Large MeningiomasCompletedNCT02974127
- Oncological Care for Patients With MeningiomaStatus unknownNCT02973256
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Effects of Scalp Nerve Blocks on Systemic InflammationStatus unknownNCT02939833Not applicable
- Ribociclib (LEE011) in Preoperative Glioma and Meningioma PatientsActive, not recruitingNCT02933736Early Phase 1
- Cavernous Sinus Dissection and Bleeding in MeningiomasStatus unknownNCT02863484Phase 4
- Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 MeningiomaCompletedNCT02847559Phase 2
- A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade MeningiomasActive, not recruitingNCT02693990Not applicable
- Combination of Everolimus and Octreotide LAR in Aggressive Recurrent MeningiomasCompletedNCT02333565Phase 2
- Information Presentation FormatsCompletedNCT02267928Not applicable
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal SurgeryStatus unknownNCT02084927Phase 1
- A Comparative Study of Prophylactic Anticoagulation in Meningioma SurgeryCompletedNCT01941602
- Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic MeningiomaActive, not recruitingNCT01892397Not applicable
- Exploring the Activity of RAD001 in Vestibular Schwannomas and MeningiomasCompletedNCT01880749Early Phase 1
- The Etiology and Progression of Brain TumorsCompletedNCT01811524
- Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial.WithdrawnNCT01795300Not applicable
- Efficacy of Tranexamic Acid in Brain Tumor ResectionsStatus unknownNCT01655927Phase 3
- Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain TumorsTerminatedNCT01324635Phase 1
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable